2.38
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Rani Therapeutics’ Share Price Surges Following Chugai Partnership - timothysykes.com
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectory2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
MSN Money - MSN
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Wall Street Watch & Reliable Intraday Trade Alerts - newser.com
Will Rani Therapeutics Holdings Inc. stock attract more institutional investorsJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationRate Hike & Verified Momentum Stock Watchlist - newser.com
Will Rani Therapeutics Holdings Inc. bounce back from current supportJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Can momentum traders help lift Rani Therapeutics Holdings Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Rani Therapeutics: Underdog to Top Performer? - StocksToTrade
Short interest data insights for Rani Therapeutics Holdings Inc.Earnings Recap Report & Consistent Return Strategy Ideas - newser.com
How high can Rani Therapeutics Holdings Inc. stock goMarket Growth Report & Community Consensus Stock Picks - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionCEO Change & Verified Short-Term Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthDividend Hike & Weekly High Return Stock Forecasts - newser.com
Multi asset correlation models including Rani Therapeutics Holdings Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Rani Therapeutics’ Strategic Partnerships Elevate Market Presence - timothysykes.com
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential - MSN
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Promising Penny Stocks To Follow TodayOctober 21st - MarketBeat
Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - MSN
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Rani Therapeutics Holdings, Inc. (RANI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Rani Therapeutics Holdings, Inc. (RANI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Rani Therapeutics (RANI) director gets 100,000 options at $2.09 | RANI SEC FilingForm 4 - Stock Titan
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times
Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):